Development of voriconazole loaded large porous particles for inhalation delivery: effect of surface forces on aerosolisation performance, assessment of in vitro safety potential and uptake by macrophages-Reference-Cited by-同舟云学术

Development of voriconazole loaded large porous particles for inhalation delivery: effect of surface forces on aerosolisation performance, assessment of in vitro safety potential and uptake by macrophages

Published:2015 Issue:48 Volume:5 Page:38030-38043
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Arora Sumit¹²³⁴⁵,Mahajan Rahul R.¹²³⁴⁵,Kushwah Varun¹²³⁴⁵,Baradia Dipesh⁶⁷⁸⁹¹⁰,Misra Ambikanandan⁶⁷⁸⁹¹⁰,Jain Sanyog¹²³⁴⁵

Affiliation:

1. Centre for Pharmaceutical Nanotechnology

2. Department of Pharmaceutics

3. National Institute of Pharmaceutical Education and Research (NIPER)

4. Mohali

5. India

6. TIFAC-CORE in NDDS

7. Pharmacy Department

8. Faculty of Technology and Engineering

9. The Maharaja Sayajirao University of Baroda

10. Vadodara-390 001

Abstract

Inhalation delivery of voriconazole loaded large porous particles represent an effective and safe way to prolong pulmonary residence of voriconazole.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2015/RA/C5RA00248F

Reference43 articles.

1. Advances and challenges in management of invasive mycoses

2. Evaluation and management of Fungal infections in Immunocompromised patients

3. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

4. Report from the 4th Advances Against Aspergillosis Conference

5. Diagnostic challenges and recent advances in the early management of invasive fungal infections

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly effective inhalable voriconazole-loaded nanomicelles for fungal infections in cystic fibrosis patients: A promising therapeutic strategy for allergic bronchopulmonary aspergillosis;Journal of Drug Delivery Science and Technology;2024-10

2. Green composites materials as a carrier for pulmonary drug delivery;Green Sustainable Process for Chemical and Environmental Engineering and Science;2023

3. Aerosolizable Lipid-Nanovesicles Encapsulating Voriconazole Effectively Permeate Pulmonary Barriers and Target Lung Cells;Frontiers in Pharmacology;2022-03-10

4. Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses;Current Pharmaceutical Design;2021-04

5. Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention;Journal of Nanobiotechnology;2021-01-11